The landscape of Healthcare Information Technology is rapidly changing leaving many EMR vendors searching for answers about how to develop their systems. It also has caused confusion among clinicians as to what actually defines meaningful use of those systems.
For those seeking clarity as to the direction of healthcare, a recent report by the Department of Health and Human Services defines the National Strategy for Quality Improvement in Healthcare. It is interesting to note that Lexicomp content can help achieve the number one goal outlined in this report - safer care by reducing the number of serious adverse drug events.
Lexicomp's transactional drug data and reference information supports various components of Stage 1 meaningful use and certification criteria from ONC's Final Rule, specifically the implementation of electronic clinical decision support rules (drug-to-drug and drug allergy contraindication checking) based on the data elements included in: problem list, medication list, demographics and laboratory test results.
Lexi-Data, Lexicomp's clinical decision support database, will help you meet several aspects of clinical decision support required for certification. Here's how:
Drug Interaction Data - we'll provide your system data that enables clinicians to screen for drug interactions, including drug-allergy, drug-drug and drug-food
RxNorm Mapping - we promote interoperability through mapping to industry standard RxNorm
Drug Reference Data - integrate drug reference information, such as drug images and black box warnings, into your system
Patient Education Data - we provide patient education information that allows users to generate patient-specific handouts for medications (available in 19 languages), and conditions and procedures (available in English and Spanish)
Dose Range Checking - we provide data that enables clinicians to receive dosing alerts for medications, including limits for pediatric patients
Lexi-Data is designed for easy implementation. Our intuitive database design will help you seamlessly integrate complex drug databases into your system.
For those seeking clarity as to the direction of healthcare, a recent report by the Department of Health and Human Services defines the National Strategy for Quality Improvement in Healthcare. It is interesting to note that Lexicomp content can help achieve the number one goal outlined in this report - safer care by reducing the number of serious adverse drug events.
Lexicomp's transactional drug data and reference information supports various components of Stage 1 meaningful use and certification criteria from ONC's Final Rule, specifically the implementation of electronic clinical decision support rules (drug-to-drug and drug allergy contraindication checking) based on the data elements included in: problem list, medication list, demographics and laboratory test results.
Lexi-Data, Lexicomp's clinical decision support database, will help you meet several aspects of clinical decision support required for certification. Here's how:
Drug Interaction Data - we'll provide your system data that enables clinicians to screen for drug interactions, including drug-allergy, drug-drug and drug-food
RxNorm Mapping - we promote interoperability through mapping to industry standard RxNorm
Drug Reference Data - integrate drug reference information, such as drug images and black box warnings, into your system
Patient Education Data - we provide patient education information that allows users to generate patient-specific handouts for medications (available in 19 languages), and conditions and procedures (available in English and Spanish)
Dose Range Checking - we provide data that enables clinicians to receive dosing alerts for medications, including limits for pediatric patients
Lexi-Data is designed for easy implementation. Our intuitive database design will help you seamlessly integrate complex drug databases into your system.
Powered by Compendium
No doubt, the landscape of healthcare information is changing rapidly. From a drug information standpoint, the key is how can we make the systems smarter to reduce risk. You have listed very important categories.
-- Drug interaction data
-- Drug reference data
-- Dose range checking
-- Allergy interaction checking.
Hopefully the companies developing new EMR systems will proactively look at these areas.